Advanced Medical Isotope Price to Sales Ratio 2013-2025 | RDGL
Historical PS ratio values for Advanced Medical Isotope (RDGL) over the last 10 years. The current P/S ratio for Advanced Medical Isotope as of May 20, 2025 is .
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
| Advanced Medical Isotope P/S Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM Sales per Share | Price to Sales Ratio |
| 2025-05-19 | 0.13 | 1122.18 | |
| 2025-03-31 | 0.12 | $0.00 | 0.00 |
| 2024-12-31 | 0.11 | $0.00 | 0.00 |
| 2024-09-30 | 0.16 | $0.00 | 0.00 |
| 2024-06-30 | 0.20 | $0.00 | 0.00 |
| 2024-03-31 | 0.07 | $0.00 | 0.00 |
| 2023-12-31 | 0.07 | $0.00 | 0.00 |
| 2023-09-30 | 0.07 | $0.00 | 0.00 |
| 2023-06-30 | 0.05 | $0.00 | 0.00 |
| 2023-03-31 | 0.07 | $0.00 | 0.00 |
| 2022-12-31 | 0.04 | $0.00 | 0.00 |
| 2022-09-30 | 0.05 | $0.00 | 0.00 |
| 2022-06-30 | 0.07 | $0.00 | 0.00 |
| 2022-03-31 | 0.07 | $0.00 | 0.00 |
| 2021-12-31 | 0.08 | $0.00 | 0.00 |
| 2021-09-30 | 0.12 | $0.00 | 0.00 |
| 2021-06-30 | 0.12 | $0.00 | 0.00 |
| 2021-03-31 | 0.10 | $0.00 | 0.00 |
| 2020-12-31 | 0.11 | $0.00 | 0.00 |
| 2020-09-30 | 0.03 | $0.00 | 0.00 |
| 2020-06-30 | 0.04 | $0.00 | 0.00 |
| 2020-03-31 | 0.03 | $0.00 | 0.00 |
| 2019-12-31 | 0.04 | $0.00 | 0.00 |
| 2019-09-30 | 0.04 | $0.00 | 0.00 |
| 2019-06-30 | 0.03 | 0 | 0.00 |
| 2019-03-31 | 0.02 | 0 | 0.00 |
| 2018-12-31 | 0.06 | 0 | 0.00 |
| 2018-09-30 | 0.14 | 0 | 0.00 |
| 2018-06-30 | 0.02 | 0 | 0.00 |
| 2018-03-31 | 0.24 | 0 | 0.00 |
| 2017-12-31 | 0.40 | $0.00 | 0.00 |
| 2017-09-30 | 0.57 | $0.00 | 0.00 |
| 2017-06-30 | 0.66 | $0.00 | 0.00 |
| 2017-03-31 | 1.21 | $0.00 | 0.00 |
| 2016-12-31 | 1.40 | $0.00 | 0.00 |
| 2016-09-30 | 1.68 | $0.00 | 0.00 |
| 2016-06-30 | 2.96 | $0.01 | 0.00 |
| 2016-03-31 | 3.76 | $0.01 | 0.00 |
| 2015-12-31 | 1.84 | $0.01 | 174.86 |
| 2015-09-30 | 1.12 | $0.01 | 106.43 |
| 2015-06-30 | 0.72 | $0.01 | 0.00 |
| 2015-03-31 | 2.80 | $0.06 | 43.55 |
| 2014-12-31 | 0.72 | $0.16 | 4.38 |
| 2014-09-30 | 2.88 | $-0.03 | 0.00 |
| 2014-06-30 | 17.52 | $0.87 | 20.06 |
| 2014-03-31 | 39.84 | $1.01 | 39.36 |
| 2013-12-31 | 50.40 | $1.13 | 44.41 |
| 2013-09-30 | 38.40 | $2.17 | 17.68 |
| 2013-06-30 | 48.00 | $1.95 | 24.58 |
| 2013-03-31 | 100.80 | $2.47 | 40.73 |
| 2012-12-31 | 148.00 | $2.79 | 53.07 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Finance | Finance - SBIC & Commercial | $0.056B | $0.000B |
| Vivos Inc. is a late stage development company. It engaged primarily in the development of brachytherapy devices for therapeutic applications. Vivos Inc., formerly known as Advanced Medical Isotope Corporation, is based in Richland, Washington. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Ares Capital (ARCC) | United States | $15.265B | 9.82 |
| Blackstone Secured Lending Fund (BXSL) | United States | $7.289B | 9.21 |
| FS KKR Capital (FSK) | United States | $5.991B | 7.64 |
| Main Street Capital (MAIN) | United States | $5.052B | 14.05 |
| Golub Capital BDC (GBDC) | United States | $4.044B | 8.77 |
| Hercules Capital (HTGC) | United States | $3.133B | 9.11 |
| Sixth Street Specialty Lending (TSLX) | United States | $2.166B | 9.85 |
| Morgan Stanley Direct Lending Fund (MSDL) | United States | $1.746B | 8.34 |
| Goldman Sachs BDC (GSBD) | United States | $1.325B | 5.57 |
| New Mountain Finance (NMFC) | United States | $1.169B | 8.09 |
| Kayne Anderson BDC (KBDC) | United States | $1.156B | 8.54 |
| Bain Capital Specialty Finance (BCSF) | United States | $1.033B | 7.73 |
| BARINGS BDC, INC (BBDC) | United States | $0.977B | 7.60 |
| Trinity Capital (TRIN) | United States | $0.967B | 7.09 |
| Amalgamated Financial (AMAL) | United States | $0.952B | 8.79 |
| Nuveen Churchill Direct Lending (NCDL) | United States | $0.806B | 7.16 |
| Carlyle Secured Lending (CGBD) | United States | $0.730B | 7.62 |
| Fidus Investment (FDUS) | United States | $0.708B | 9.02 |
| BLACKROCK TCP CAPITAL CORP (TCPC) | United States | $0.658B | 5.09 |
| Gladstone Capital (GLAD) | United States | $0.605B | 13.10 |
| Crescent Capital BDC (CCAP) | United States | $0.586B | 7.09 |
| Gladstone Investment (GAIN) | United States | $0.550B | 15.39 |
| CION Investment (CION) | United States | $0.524B | 6.46 |
| Palmer Square Capital BDC (PSBD) | United States | $0.452B | 7.68 |
| PennantPark Investment (PNNT) | United States | $0.451B | 8.23 |
| Stellus Capital Investment (SCM) | United States | $0.389B | 8.34 |
| Saratoga Investment Corp (SAR) | United States | $0.380B | 6.43 |
| Runway Growth Finance (RWAY) | United States | $0.366B | 6.16 |
| Horizon Technology Finance (HRZN) | United States | $0.302B | 6.14 |
| TriplePoint Venture Growth BDC (TPVG) | United States | $0.277B | 5.42 |
| Chicago Atlantic BDC (LIEN) | United States | $0.240B | 40.46 |
| Medallion Financial (MFIN) | United States | $0.215B | 5.78 |
| WhiteHorse Finance (WHF) | United States | $0.214B | 6.49 |
| Oxford Square Capital (OXSQ) | United States | $0.173B | 5.90 |
| PhenixFIN (PFX) | United States | $0.102B | 20.06 |
| Rand Capital (RAND) | United States | $0.049B | 9.34 |
| Logan Ridge Finance (LRFC) | United States | $0.048B | 11.51 |
| Investcorp Credit Management BDC (ICMB) | United States | $0.044B | 8.64 |
| SLR Investment (SLRC) | United States | $0.000B | 9.58 |
| OFS Capital (OFS) | United States | $0.000B | 7.99 |